WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Sartorius Stedim Biotech S.A. (DIM) - Financial and Strategic SWOT Analysis Review

GlobalData, March 2013, Pages: 43

Summary

Sartorius Stedim Biotech S.A. (SSB) is a leading supplier to the pharmaceutical and biotech industries. It provides equipment, and laboratory and process technologies for the production processes of medicines. SSB categorizes its services into validation services, process analysis, training, process optimization, instrument services, spare parts and consumables and information on disposal. The company's product portfolio comprises various types of filters, analyzers, process control tools, UV-C inactivation systems, bioreactors, fermentors, incubation shakers, containers, and mixing systems, among others.

Sartorius Stedim Biotech S.A. Key Recent Developments

Feb 27, 2013: Sartorius Stedim Biotech Expands PAT Portfolio By Adding Sensor Technology For Real-Time Biomass Measurement
Jan 29, 2013: Sartorius Stedim Reports Revenue Of €544m In 2012
Jan 25, 2013: Sartorius's New Manufacturing Facility In Puerto Rico Receives LEED Platinum Certification
Dec 19, 2012: Sartorius Stedim Partners With Lonza To Expand Portfolio By Adding Cell Culture Media
Dec 18, 2012: Sartorius Stedim And Umetrics Form Partnership To Optimize Biopharmaceutical Development And Manufacturing ProcessesGDPH81754FSA

This comprehensive SWOT profile of Sartorius Stedim Biotech S.A. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Sartorius Stedim Biotech S.A. - Key Facts
Sartorius Stedim Biotech S.A. - Key Employees
Sartorius Stedim Biotech S.A. - Key Employee Biographies
Sartorius Stedim Biotech S.A. - Major Products and Services
Sartorius Stedim Biotech S.A. - History
Sartorius Stedim Biotech S.A. - Company Statement
Sartorius Stedim Biotech S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Sartorius Stedim Biotech S.A. - Business Description
Sartorius Stedim Biotech S.A. - Corporate Strategy
Sartorius Stedim Biotech S.A. - SWOT Analysis
SWOT Analysis - Overview
Sartorius Stedim Biotech S.A. - Strengths
Strength - Wide Geographical Presence
Strength - Comprehensive Portfolio of Products and Services
Strength - Consistent Increase in Revenue
Sartorius Stedim Biotech S.A. - Weaknesses
Weakness - Huge Debt
Sartorius Stedim Biotech S.A. - Opportunities
Opportunity - Capacity Expansion Initiatives
Opportunity - Market Potential: Single-Use Technologies
Opportunity - Strategic Agreements and Collaboration
Opportunity - Emerging Markets
Sartorius Stedim Biotech S.A. - Threats
Threat - Foreign Currency Exchange Rate Risk
Threat - Competitive Pressures
Threat - Rapid Technological Change
Sartorius Stedim Biotech S.A. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sartorius Stedim Biotech S.A., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Medical Equipment, Deals By Year, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Medical Equipment, Deals By Type, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Recent Deals Summary
Section 5 – Company’s Recent Developments
Sartorius Stedim Biotech S.A., Recent Developments
Feb 27, 2013: Sartorius Stedim Biotech Expands PAT Portfolio By Adding Sensor Technology For Real-Time Biomass Measurement
Jan 29, 2013: Sartorius Stedim Reports Revenue Of €544m In 2012
Jan 25, 2013: Sartorius's New Manufacturing Facility In Puerto Rico Receives LEED Platinum Certification
Dec 19, 2012: Sartorius Stedim Partners With Lonza To Expand Portfolio By Adding Cell Culture Media
Dec 18, 2012: Sartorius Stedim And Umetrics Form Partnership To Optimize Biopharmaceutical Development And Manufacturing Processes
Oct 29, 2012: Sartorius Stedim Reports Revenue Of €413.1m For Nine Months Ended September 30, 2012
Jul 25, 2012: Sartorius Stedim Reports Revenue Of €272.6m In H1 2012
Jun 19, 2012: Sartorius Introduces New Generation Of Sterilizing-Grade Filters
Apr 24, 2012: Sartorius Stedim Reports Revenue Of €133.5m In Q1 2012
Apr 13, 2012: Sartorius Opens New Manufacturing Building At Goettingen, Germany
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Sartorius Stedim Biotech S.A., Key Facts
Sartorius Stedim Biotech S.A., Key Employees
Sartorius Stedim Biotech S.A., Key Employee Biographies
Sartorius Stedim Biotech S.A., Major Products and Services
Sartorius Stedim Biotech S.A., History
Sartorius Stedim Biotech S.A., Subsidiaries
Sartorius Stedim Biotech S.A., Key Competitors
Sartorius Stedim Biotech S.A., Ratios based on current share price
Sartorius Stedim Biotech S.A., Annual Ratios
Sartorius Stedim Biotech S.A., Interim Ratios
Sartorius Stedim Biotech S.A., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Medical Equipment, Deals By Year, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Medical Equipment, Deals By Type, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sartorius Stedim Biotech S.A., Performance Chart (2007 - 2011)
Sartorius Stedim Biotech S.A., Ratio Charts
Sartorius Stedim Biotech S.A., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Medical Equipment, Deals By Year, 2007 to YTD 2013
Sartorius Stedim Biotech S.A., Medical Equipment, Deals by Type, 2007 to YTD 2013

Cellectis S.A.
DNA Therapeutics S.A.
BioProtein Technologies
Biosiris_RA
SynapCell
Thermo Fisher Scientific Inc.
New Brunswick Scientific Co., Inc.
EMD Millipore
Applikon Biotechnology B.V.

Customers who bought this item also bought